(Q74460248)
Statements
A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation (English)
Pecora AL
Stiff P
LeMaistre CF
Bayer R
Bachier C
Goldberg SL
Parthasarathy M
Jennis AA
Smith AK
Douville J
Chen B
Armstrong RD
Mandalam RK